Prognosis
Imbed Biosciences Chases Nasal Spray to Combat Covid-19 Spread
- Lab data show nanoparticles can kill 99.9% of Covid viruses
- Next step is to get FDA signoff for trials of spray in humans
This article is for subscribers only.
Imbed Biosciences Inc., a closely-held biotech that makes a product for pain and infections in complex wounds, says a reformulation of its biggest product as a nasal spray could help prevent the spread of Covid-19.
The Madison, Wisconsin-based company says it has developed an antiviral formulation of silver nanoparticles, based on its already U.S. approved Microlyte Matrix wound therapy, which could be used to prevent the early spread of Covid-19. The company hopes to start testing the spray in patients soon.